Cellectar Biosciences Insider Trades

CLRB

Track insider trading activity from Cellectar Biosciences executives and directors. See which insiders are buying and selling CLRB stock.

Trades Last 12 Months

CLRB Price

All Insider Trades for Cellectar Biosciences

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Caruso James V Chief Executive Officer
Holding Value $93.8k 36,076 shares
Last Trade
May 07, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$85.9k 26,040 shares
$3.30
$2.60
Longcor Jarrod Chief Operating Officer
Holding Value $94k 36,149 shares
Last Trade
May 07, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$115k 34,720 shares
$3.30
$2.60
Neis John Director
Holding Value $26 10 shares
Last Trade
Dec 12, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$733 198 shares
$3.70
$2.60
Kolean Chad J Chief Financial Officer
Holding Value $16.7k 6,418 shares
Last Trade
Jul 02, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$51.2k 10,000 shares
$5.12
$2.60
Holding Value $234k 90,000 shares
Last Trade
Feb 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$785k 90,000 shares
$8.72
$2.60
Holding Value $156k 60,000 shares
Last Trade
Feb 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$523k 60,000 shares
$8.72
$2.60
Holding Value $156k 60,000 shares
Last Trade
Feb 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$523k 60,000 shares
$8.72
$2.60
Loren Stefan Director
Holding Value $156k 60,000 shares
Last Trade
Feb 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$523k 60,000 shares
$8.72
$2.60
Lea Darrell Shane Chief Commercial Officer
Holding Value $676k 260,000 shares
Last Trade
Jun 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25.1M 260,000 shares
$96.60
$2.60
Shustov Andrei Senior Vice President, Medical
Holding Value $676k 260,000 shares
Last Trade
Jun 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25.1M 260,000 shares
$96.60
$2.60
Elefant Dov Chief Financial Officer
Holding Value $1.1M 422,000 shares
Last Trade
Jan 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$69.6M 422,000 shares
$165.00
$2.60
Friend John E. Ii Chief Medical Officer
Holding Value $858k 330,000 shares
Last Trade
Mar 04, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$172M 330,000 shares
$522.00
$2.60
Hill Stephen A Director
Holding Value $130k 50,000 shares
Last Trade
Jun 24, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.2M 50,000 shares
$384.00
$2.60
Grachev Igor D Chief Medical Officer
Holding Value $208k 80,000 shares
Last Trade
Jan 06, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59M 80,000 shares
$738.00
$2.60
Posner Brian M Chief Financial Officer
Holding Value $78k 30,000 shares
Last Trade
Jan 17, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.9M 30,000 shares
$597.00
$2.60
Holding Value $728k 280,000 shares
Last Trade
Oct 31, 2016 Sale (Open Market)Shares sold on the open market or in a private sale.
$117M 21,000 shares
$5,550.00
$2.60
Weichert Jamey P Chief Scientific Officer
Holding Value $112k 42,895 shares
Last Trade
May 12, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$178M 40,000 shares
$4,440.00
$2.60
Holding Value $0 0 shares
Last Trade
Apr 20, 2016 Sale
$2.89B 469,484 shares
$6,150.00
$2.60
Berns Paul L Director
Holding Value $305k 117,371 shares
Last Trade
Apr 20, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$722M 117,371 shares
$6,150.00
$2.60
Holding Value $0 0 shares
Last Trade
Dec 31, 2015 Sale (Open Market)Shares sold on the open market or in a private sale.
$783M 35,253 shares
$22,200.00
$2.60

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up